Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bacterial Infections and Mycoses

  Free Subscription


1 Am J Clin Pathol
2 Am J Respir Crit Care Med
1 Am J Trop Med Hyg
2 Antimicrob Agents Chemother
12 Clin Infect Dis
2 Curr Microbiol
17 J Antimicrob Chemother
1 J Bacteriol
1 J Biol Chem
3 J Clin Invest
2 J Clin Microbiol
2 J Infect Dis
1 J Med Chem
3 J Med Microbiol
6 PLoS Negl Trop Dis
7 PLoS One
2 PLoS Pathog
4 Proc Natl Acad Sci U S A
1 Science

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Pathol

  1. COX BK, Larson BK, Hutchings DA, Morgan M, et al
    The Histopathology of Anorectal Neisseria gonorrhoeae Infection.
    Am J Clin Pathol. 2022;158:559-563.
    PubMed         Abstract available

    Am J Respir Crit Care Med

    Tuberculosis, Wildfires, and Case-Crossover Studies: An Epidemiological Trifecta?
    Am J Respir Crit Care Med. 2022 Oct 31. doi: 10.1164/rccm.202210-1936.

  3. BEENTJES D, Shears RK, French N, Neill DR, et al
    Mechanistic Insights into the Impact of Air Pollution on Pneumococcal Pathogenesis and Transmission.
    Am J Respir Crit Care Med. 2022;206:1070-1080.
    PubMed         Abstract available

    Am J Trop Med Hyg

  4. DE OLIVEIRA JERONYMO NEVES AC, Gomes Dos Santos AP, de Medeiros RL, de Oliveira Jeronymo AJ, et al
    Sociodemographic and Clinical Factors Associated with Treatment Outcomes for Drug-resistant Tuberculosis.
    Am J Trop Med Hyg. 2022 Oct 31. pii: tpmd220294. doi: 10.4269/ajtmh.22-0294.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  5. CABELLOS C, Guillem L, Pelegrin I, Tubau F, et al
    Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
    Antimicrob Agents Chemother. 2022 Nov 3:e0082022. doi: 10.1128/aac.00820.
    PubMed         Abstract available

  6. NGUYEN TQ, Hanh BTB, Jeon S, Heo BE, et al
    Synergistic Effect of Q203 Combined with PBTZ169 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Nov 2:e0044822. doi: 10.1128/aac.00448.
    PubMed         Abstract available


  7. HASAN SB, Harris C, Collier F
    Hidradenitis suppurativa.
    BMJ. 2022;379:e068383.

    Clin Infect Dis

  8. RHEE C, Baker MA, Tucker R, Vaidya V, et al
    Cluster of Burkholderia cepacia Complex Infections Associated With Extracorporeal Membrane Oxygenation Water Heater Devices.
    Clin Infect Dis. 2022;75:1610-1617.
    PubMed         Abstract available

  9. ABY ES, Vaughn BP, Enns EA, Rajasingham R, et al
    Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.
    Clin Infect Dis. 2022;75:1602-1609.
    PubMed         Abstract available

  10. RAUSCH CR, DiPippo AJ, Jiang Y, DiNardo CD, et al
    Comparison of mold active triazoles as primary antifungal prophylaxis in patients with newly diagnosed acute myeloid leukemia in the era of molecularly targeted therapies.
    Clin Infect Dis. 2022 Mar 23. pii: 6553300. doi: 10.1093.
    PubMed         Abstract available

  11. HOLLAND TL, Bayer AS, Fowler VG
    Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.
    Clin Infect Dis. 2022;75:1668-1674.
    PubMed         Abstract available

  12. GREENTREE DH, Rice LB, Donskey CJ
    Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin Susceptibility.
    Clin Infect Dis. 2022;75:1661-1664.
    PubMed         Abstract available

  13. ALLAN-BLITZ LT, Adamson PC, Klausner JD
    Resistance-Guided Therapy for Neisseria gonorrhoeae.
    Clin Infect Dis. 2022;75:1655-1660.
    PubMed         Abstract available

  14. LUTGRING JD, McKay SL, Gargis AS, Halpin AL, et al
    Are Vancomycin Non-Susceptible Clostridioides difficile Strains Emerging?
    Clin Infect Dis. 2022;75:1677-1678.

  15. LOUIE JK, Keh C, Agraz-Lara R, Phillips A, et al
    Adverse Events Associated with Treatment for Pan-susceptible Tuberculosis in San Francisco.
    Clin Infect Dis. 2022 Nov 2. pii: 6793979. doi: 10.1093.
    PubMed         Abstract available

  16. Correction to: Herpes Simplex Virus 2 Meningitis in Adults: A Prospective, Nationwide, Population-Based Cohort Study.
    Clin Infect Dis. 2022 Nov 2. pii: 6794017. doi: 10.1093.

  17. NDEGE R, Ngome O, Vanobberghen F, Bani F, et al
    Ultrasound in managing extrapulmonary tuberculosis: A randomised, controlled, parallel, superiority, open-label trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6801068. doi: 10.1093.
    PubMed         Abstract available

  18. MANGNER N, Panagides V, Del Val D, Abdel-Wahab M, et al
    Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients with Infective Endocarditis after Transcatheter Aortic Valve Implantation.
    Clin Infect Dis. 2022 Nov 4. pii: 6801102. doi: 10.1093.
    PubMed         Abstract available

  19. HOLMGAARD FB, Guglielmetti L, Lillebaek T, Andersen AB, et al
    Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Clin Infect Dis. 2022 Nov 4. pii: 6801118. doi: 10.1093.
    PubMed         Abstract available

    Curr Microbiol

  20. HERNANDEZ LB, Cadona JS, Traverso F, Altamiranda SM, et al
    Virulence Profiles and Antimicrobial Resistance of Streptococcus agalactiae Infective and Colonizing Strains from Argentina.
    Curr Microbiol. 2022;79:392.
    PubMed         Abstract available

  21. ROSA DS, Oliveira SAS, Souza RFS, Neto AAS, et al
    Characterization of Multidrug-Resistant Staphylococcus aureus Isolates and Comparison of Methods of Susceptibility to Vancomycin.
    Curr Microbiol. 2022;79:374.
    PubMed         Abstract available

    J Antimicrob Chemother

  22. AYFAN AKS, Macdonald J, Irwin AD, Zowawi HM, et al
    Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2022;77:2933-2936.
    PubMed         Abstract available

  23. PALKOVICOVA J, Sukkar I, Delafuente J, Valcek A, et al
    Fitness effects of blaCTX-M-15-harbouring F2:A1:B- plasmids on their native Escherichia coli ST131 H30Rx hosts.
    J Antimicrob Chemother. 2022;77:2960-2963.
    PubMed         Abstract available

  24. WANG PL, Liu P, Zhang QW, Yuan WH, et al
    Population pharmacokinetics and clinical outcomes of polymyxin B in paediatric patients with multidrug-resistant Gram-negative bacterial infections.
    J Antimicrob Chemother. 2022;77:3000-3008.
    PubMed         Abstract available

  25. FONG W, Timms V, Sim E, Pey K, et al
    Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667673. doi: 10.1093.
    PubMed         Abstract available

  26. BRUNA RE, Casal A, Bercovich B, Gramajo H, et al
    A natural product from Streptomyces targets PhoP and exerts antivirulence action against Salmonella enterica.
    J Antimicrob Chemother. 2022;77:3050-3063.
    PubMed         Abstract available

  27. ZHAO X, Huang H, Yuan H, Yuan Z, et al
    A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.
    J Antimicrob Chemother. 2022;77:3210-3211.

  28. PITT R, Boampong D, Day M, Jensen JS, et al
    Challenges of in vitro propagation and antimicrobial susceptibility testing of Mycoplasma genitalium.
    J Antimicrob Chemother. 2022;77:2901-2907.
    PubMed         Abstract available

  29. SUMI CD, Heffernan AJ, Naicker S, Cottrell K, et al
    Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates.
    J Antimicrob Chemother. 2022;77:3026-3034.
    PubMed         Abstract available

  30. TAM VH, Merlau PR, Hudson CS, Kline EG, et al
    Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:3130-3137.
    PubMed         Abstract available

  31. RIGATTO MH, Ramos F, Barros A, Pedroso S, et al
    Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
    J Antimicrob Chemother. 2022 Sep 1. pii: 6681124. doi: 10.1093.
    PubMed         Abstract available

  32. HERNANDEZ-GARCIA M, Garcia-Castillo M, Melo-Cristino J, Pinto MF, et al
    In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies).
    J Antimicrob Chemother. 2022;77:3163-3172.
    PubMed         Abstract available

  33. LASKO MJ, Tabor-Rennie JL, Nicolau DP, Kuti JL, et al
    Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
    J Antimicrob Chemother. 2022;77:3187-3193.
    PubMed         Abstract available

  34. NOTERMANS DW, Schoffelen AF, Landman F, Wielders CCH, et al
    A genetic cluster of OXA-244 carbapenemase-producing Escherichia coli ST38 with putative uropathogenicity factors in the Netherlands.
    J Antimicrob Chemother. 2022;77:3205-3208.

  35. WITT LS, Burd EM, Ozturk T, Satola SW, et al
    'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.
    J Antimicrob Chemother. 2022;77:3212.

  36. TRIPONNEY P, Bour M, Beyrouthy R, Bonnet R, et al
    Role of megaplasmids and chromosomal integration in acquisition of CTX-M-encoding genes by Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:3194-3198.

  37. KELENTSE N, Moyo S, Choga WT, Lechiile K, et al
    High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794066. doi: 10.1093.
    PubMed         Abstract available

  38. CASTRO BE, Rios R, Carvajal LP, Vargas ML, et al
    Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794061. doi: 10.1093.
    PubMed         Abstract available

    J Bacteriol

  39. RUED BE, Anderson CM, Federle MJ
    The Proteomic and Transcriptomic Landscapes Altered by Rgg2/3 Activity in Streptococcus pyogenes.
    J Bacteriol. 2022 Oct 31:e0017522. doi: 10.1128/jb.00175.
    PubMed         Abstract available

    J Biol Chem

  40. LUO J, Ruan X, Huang Z, Li Z, et al
    Structural basis for the dual catalytic activity of the Legionella pneumophila ovarian tumor (OTU) domain deubiquitinase LotA.
    J Biol Chem. 2022;298:102414.
    PubMed         Abstract available

    J Clin Invest

  41. DANIEL L, Bhattacharyya ND, Counoupas C, Cai Y, et al
    Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis-infected mice.
    J Clin Invest. 2022;132.
    PubMed         Abstract available

  42. STROBL J, Mundler V, Muller S, Gindl A, et al
    Tick feeding modulates the human skin immune landscape to facilitate tick-borne pathogen transmission.
    J Clin Invest. 2022;132.
    PubMed         Abstract available

  43. FISCHER AS, Mullerke S, Arnold A, Heuberger J, et al
    R-spondin/YAP axis promotes gastric oxyntic gland regeneration and Helicobacter pylori-associated metaplasia in mice.
    J Clin Invest. 2022;132.
    PubMed         Abstract available

    J Clin Microbiol

  44. BARKER KR, Kus JV, Normand AC, Gharabaghi F, et al
    A Practical Workflow for the Identification of Aspergillus, Fusarium, Mucorales by MALDI-TOF MS: Database, Medium, and Incubation Optimization.
    J Clin Microbiol. 2022 Nov 3:e0103222. doi: 10.1128/jcm.01032.
    PubMed         Abstract available

  45. CHU CM, Woo PCY, Chong KTK, Leung WS, et al
    Retraction for Chu et al., "Association of Presence of Aspergillus Antibodies with Hemoptysis in Patients with Old Tuberculosis or Bronchiectasis but No Radiologically Visible Mycetoma".
    J Clin Microbiol. 2022 Oct 31:e0142822. doi: 10.1128/jcm.01428.

    J Infect Dis

  46. POPOVICH KJ, Weinstein RA
    Questioning old Staphylococcus aureus Beliefs with New Technology.
    J Infect Dis. 2022 Nov 2. pii: 6794151. doi: 10.1093.

  47. RUSSAKOFF B, Wood C, Lininger MR, Barger SD, et al
    A quantitative assessment of Staphylococcus aureus community carriage in Yuma, Arizona.
    J Infect Dis. 2022 Nov 2. pii: 6794090. doi: 10.1093.
    PubMed         Abstract available

    J Med Chem

  48. SAINI V, Mehta D, Gupta S, Kumar S, et al
    Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates.
    J Med Chem. 2022 Nov 4. doi: 10.1021/acs.jmedchem.2c01293.
    PubMed         Abstract available

    J Med Microbiol

  49. SEO Y, Park H, Lee G
    mgpB genotyping and genetic diversity for antimicrobial resistance of Mycoplasma genitalium.
    J Med Microbiol. 2022;71.
    PubMed         Abstract available

  50. APPANEAL HJ, Lopes VV, LaPlante KL, Caffrey AR, et al
    Trends in Stenotrophomonas maltophilia antibiotic resistance rates in the United States Veterans Affairs Health System.
    J Med Microbiol. 2022;71.
    PubMed         Abstract available

  51. REILLY AS, McElligott M, Mac Dermott Casement C, Drew RJ, et al
    Haemophilus influenzae type f in the post-Haemophilus influenzae type b vaccination era: a systematic review.
    J Med Microbiol. 2022;71.
    PubMed         Abstract available

    PLoS Negl Trop Dis

  52. TER ELLEN F, Tielens K, Fenenga C, Mieras L, et al
    Implementation approaches for leprosy prevention with single-dose rifampicin: A support tool for decision making.
    PLoS Negl Trop Dis. 2022;16:e0010792.
    PubMed         Abstract available

  53. SIKORSKI MJ, Ma J, Hazen TH, Desai SN, et al
    Spatial-temporal and phylogenetic analyses of epidemiologic data to help understand the modes of transmission of endemic typhoid fever in Samoa.
    PLoS Negl Trop Dis. 2022;16:e0010348.
    PubMed         Abstract available

  54. GARCIA BARDALES PF, Schiaffino F, Huynh S, Paredes Olortegui M, et al
    "Candidatus Campylobacter infans" detection is not associated with diarrhea in children under the age of 2 in Peru.
    PLoS Negl Trop Dis. 2022;16:e0010869.
    PubMed         Abstract available

  55. HOUNSOME N, Hassan R, Bakhiet SM, Deribe K, et al
    Role of socioeconomic factors in developing mycetoma: Results from a household survey in Sennar State, Sudan.
    PLoS Negl Trop Dis. 2022;16:e0010817.
    PubMed         Abstract available

  56. LOCKWOOD DN, McIntosh A, Armstrong M, Checkley AM, et al
    Diagnosing and treating leprosy in a non-endemic setting in a national centre, London, United Kingdom 1995-2018.
    PLoS Negl Trop Dis. 2022;16:e0010799.
    PubMed         Abstract available

  57. LITVINTSEVA AP, Bakhiet S, Gade L, Wagner DD, et al
    Genomics and metagenomics of Madurella mycetomatis, a causative agent of black grain mycetoma in Sudan.
    PLoS Negl Trop Dis. 2022;16:e0010787.
    PubMed         Abstract available

    PLoS One

  58. SHAMPUTA IC, Nguyen DTK, Higazy D, Abdelhadi A, et al
    Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    PLoS One. 2022;17:e0277255.
    PubMed         Abstract available

  59. TORNU E, Quarcoopome L
    Correlates of quality of life among persons living with tuberculosis: A cross-sectional study.
    PLoS One. 2022;17:e0277192.
    PubMed         Abstract available

  60. GUIMARAES LC, Assuncao MIMM, de Oliveira TLR, Cavalcante FS, et al
    Methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from skin and nares of Brazilian children with atopic dermatitis demonstrate high level of clonal diversity.
    PLoS One. 2022;17:e0276960.
    PubMed         Abstract available

  61. CHARYPKHAN D, Ruegg SR
    One Health evaluation of brucellosis control in Kazakhstan.
    PLoS One. 2022;17:e0277118.
    PubMed         Abstract available

  62. DI MAMBRO T, Vanzolini T, Bianchi M, Crinelli R, et al
    Development and in vitro characterization of a humanized scFv against fungal infections.
    PLoS One. 2022;17:e0276786.
    PubMed         Abstract available

  63. IFRID E, Ouertatani-Sakouhi H, Jauslin T, Kicka S, et al
    5-ethyl-2'-deoxyuridine fragilizes Klebsiella pneumoniae outer wall and facilitates intracellular killing by phagocytic cells.
    PLoS One. 2022;17:e0269093.
    PubMed         Abstract available

  64. NAM YH, Willis SJ, Mendelsohn AB, Forrow S, et al
    Healthcare claims-based Lyme disease case-finding algorithms in the United States: A systematic literature review.
    PLoS One. 2022;17:e0276299.
    PubMed         Abstract available

    PLoS Pathog

  65. HELBLE JD, McCarthy JE, Sawden M, Starnbach MN, et al
    The PD-1/PD-L1 pathway is induced during Borrelia burgdorferi infection and inhibits T cell joint infiltration without compromising bacterial clearance.
    PLoS Pathog. 2022;18:e1010903.
    PubMed         Abstract available

  66. GILCHRIST JJ, Auckland K, Parks T, Mentzer AJ, et al
    Genome-wide association study of leprosy in Malawi and Mali.
    PLoS Pathog. 2022;18:e1010312.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  67. HUANG CC, Trevisi L, Becerra MC, Calderon RI, et al
    Spatial scale of tuberculosis transmission in Lima, Peru.
    Proc Natl Acad Sci U S A. 2022;119:e2207022119.
    PubMed         Abstract available

  68. KHETRAPAL V, Ayub Ow Yong L, Lim SJM, Chen SL, et al
    Development of mass allelic exchange, a technique to enable sexual genetics in Escherichia coli.
    Proc Natl Acad Sci U S A. 2022;119:e2105458119.
    PubMed         Abstract available

  69. CONNOLLY JPR, Turner NCA, Serrano E, Rimbi PT, et al
    Control of resistance against bacteriophage killing by a metabolic regulator in meningitis-associated Escherichia coli.
    Proc Natl Acad Sci U S A. 2022;119:e2210299119.
    PubMed         Abstract available

  70. STEINIG E, Aglua I, Duchene S, Meehan MT, et al
    Phylodynamic signatures in the emergence of community-associated MRSA.
    Proc Natl Acad Sci U S A. 2022;119:e2204993119.
    PubMed         Abstract available


  71. NIKKANEN J, Leong YA, Krause WC, Dermadi D, et al
    An evolutionary trade-off between host immunity and metabolism drives fatty liver in male mice.
    Science. 2022;378:290-295.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.